| payload |
{"artifact_id":"artf_thesis_9e0c64e230 {"artifact_id":"artf_thesis_9e0c64e230c22e82","evidence_event_ids":["evt_5f907e992631","evt_b3fe7faacddb"],"kind":"opportunity_thesis","meta":{"confidence":0.3866,"lane":"monitor","morning_holdback":false,"rank_score":0.3866,"theme_keys":[],"urgency_reason":"not_urgent","urgent":false},"output_json":{"artifact_kind_detail":"research_thesis","catalysts":[],"confidence":0.3866,"decision_reason_codes":["research_thesis"],"headline":"Vaxart, Inc. filed a Form S-3 registration statement with the SEC on April 15, 2026 that includes a base prospectus and a sales agreement prospectus supplement covering up to $300,000,000 of securities (including $49,772,479 of common st...","investigation_questions":["The provided text does not include the full registration statement details (e.g., exact securities, share counts beyond the $49,772,479 r...","The signal metadata lists a filing_date of 2026-04-17T02:13:18.114675+00:00, but the article text states \"As filed ... on April 15, 2026\"..."],"portfolio_fit":{"applied":false,"boost":0.0,"exit_risk_flagged":false,"hedge_suggested":null,"matched_holdings":[],"matched_watchlist":[],"stub_version":"v1","why_you":""},"related_tickers":["VXRT"],"risk_level":"medium","theme_keys":[],"thesis":"Form S-3 \u00b7 Vaxart, Inc. \u00b7 Filed 20260416; The document is a Form S-3 registration statement under the Securities Act of 1933 for Vaxart, Inc.; The filing text states it was filed with the SEC on April 15, 2026 (\"As filed with the Securities and Exchange Commission on April 15, 2026\"). \u2014 Signal convergence: Vaxart, Inc. filed a Form S-3 registration statement with the SEC on April 15, 2026 that includes a base prospectus and a sales agreement prospectus supplement covering up to $300,000,000 of securities (including $49,772"},"ready_at":"2026-04-17T03:46:55.829000+00:00","status":"ready","summary":"Form S-3 \u00b7 Vaxart, Inc. \u00b7 Filed 20260416; The document is a Form S-3 registration statement under the Securities Act of 1933 for Vaxart, Inc.; The filing text states it was filed with the SEC on April 15, 2026 (\"As filed with the Securities and Exchange Commission on April 15, 2026\"). \u2014 Signal convergence: Vaxart, Inc. filed a Form S-3 registration statement","title":"[THESIS] VXRT \u2014 Vaxart, Inc. filed a Form S-3 registration statement with the SEC on April 15, 2026 that includes a base prospectus and a sales agreement prospectus supplement covering up to $300,000,","updated_at":"2026-04-17T03:46:55.829000+00:00"}... |